Sector: Healthcare | Industry: Healthcare Facilities & Services |
See Regulatory Filings on SEC |
Company Contact | |
Address: | 9100 South Hills Blvd Suite 300, Suite 300 BROADVIEW HEIGHTS OH 44147 |
Tel: | N/A |
Website: | https://soterahealth.com |
IR: | See website |
Key People | ||
Michael B. Petras Chairman of the Board, Chief Executive Officer | Jonathan M. Lyons Chief Financial Officer, Senior Vice President | Michael P. Rutz President of Sterigenics |
Alexander Dimitrief Senior Vice President, General Counsel, Secretary | Matthew J. Klaben Deputy General Counsel |
Business Overview |
Sotera Health Company is a global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry. The Company's segments include Sterigenics, Nordion, and Nelson Labs. The Sterigenics business provides outsourced terminal sterilization and irradiation services for the medical device, pharmaceutical, food safety and advanced applications markets using three technologies: gamma irradiation, ethylene oxide (EO) processing and E-beam irradiation. The Nordion business is a provider of Co-60 used in the sterilization and irradiation processes for the medical device, pharmaceutical, food safety, and materials industries and for the treatment of cancer. In addition, Nordion is a global provider of gamma irradiation systems. The Nelson Labs business provides outsourced microbiological and analytical chemistry testing and advisory services for the medical device and pharmaceutical industries. |
Financial Overview |
For the fiscal year ended 31 December 2023, Sotera Health Co revenues increased 5% to $1.05B. Net income applicable to common stockholders totaled $51.1M vs. loss of $233.6M. Revenues reflect Sterigenics segment increase of 6% to $667.1M, Nordion segment increase of 4% to $160.5M, Europe segment increase of 13% to $187.5M, United States segment increase of 2% to $591M. |